Claudio Dansky Ullmann
Affiliation: National Institutes of Health
- A population-based study of therapy and survival for patients with head and neck cancer treated in the communityClaudio Dansky Ullmann
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA
Cancer 118:4452-61. 2012..The objective of this study was to examine patterns of care and survival in a population-based sample of patients with head and neck cancer (HNC) who were treated in the community or in hospitals that had residency training programs...
- NF-κB as potential target in the treatment of melanomaGabriele Madonna
Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy
J Transl Med 10:53. 2012..Among these, NFκB is another pathway that melanoma tumors use to achieve survival, proliferation and resistance to apoptosis. Inhibition of NF-κB activation appears to be a very promising option for anti-cancer therapies...
- Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"Paolo A Ascierto
Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy
J Transl Med 9:32. 2011..Four topics of discussion were identified: New pathways in Melanoma, Biomarkers, Clinical Trials and New Molecules and Strategies...
- Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survivalHelen M Parsons
From the Applied Research Program, National Cancer Institute, Bethesda, MD Information Management Services, Inc, Calverton, MD and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
Cancer J 20:97-104. 2014..Whereas treatment patterns and outcomes have been evaluated for patients with SCLC in clinical trials, population-based practice patterns are not well known...